Rite-Aid (RAD) Buy Rating Reiterated at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Deutsche Bank Comments on Rite-Aid's (RAD) Q1 and FY15 Guidance
June 5, 2014 10:47 AM EDTDeutsche Bank maintained a Buy rating on Rite-Aid (NYSE: RAD) with a price target of $9.00. Earlier Rite-Aid stock declined after it provided May results and updated Q1 and FY15 guidance. Analyst... More
Rite Aid (RAD) May Comps Rose 3.5%; Guides Q1 EPS Below Consensus
June 5, 2014 8:05 AM EDTRite Aid (NYSE: RAD) announced sales results for May. The Company also provided preliminary estimated financial results for the quarter ended May 31, 2014 and updated its outlook for 2015 fiscal year.
Monthly Sales
For the five weeks ended May 31, 2014, same store sales increased 3.5 percent over the prior-year period. May front-end same store sales increased 0.5 percent. Pharmacy same store sales, which included an approximate 156 basis points negative impact from new generic introductions, increased 5.0 percent. Prescription count at comparable stores increased 3.2 percent over the prior-year period.
Total drugstore sales for the five-week period increased 2.5 percent to... More
